Pneumonia News

Increased rates of certain infections, such as influenza, gastroenteritis, hepatitis and pneumonia, appeared associated with an eventual cancer diagnosis, according to research published in Cancer Immunology Research.

In this video, Paul Steinhauser, MD, captain of the U.S. Air Force and second-year internal medicine resident at San Antonio Uniformed Services Health Education Consortium, reviews a case report of vaping-induced lung injury.

Preliminary data showed that OpGen’s Unyvero HPN Panel for pneumonia was strongly concordant with bacterial culture in the detection of organisms causing coinfection.

The FDA approved Merck’s Recarbrio today, a three-drug combination antibiotic injection for the treatment of hospital-acquired bacterial pneumonia, or HABP, and ventilator-associated bacterial pneumonia, or VABP, in patients aged 18 years and older, according to a press release from the FDA.

Older adults prescribed nitrogen-containing bisphosphonate therapy after a hip fracture were less likely to develop pneumonia or die from the infection compared with similar adults who received no osteoporosis therapy, researchers report.

The FDA today granted priority review to cefiderocol for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia.

The FDA authorized the first COVID-19 diagnostic test using home-collected saliva specimens by issuing an emergency use authorization to Rutgers Clinical Genomics Laboratory, according to an FDA press release.

New data on underlying conditions among people hospitalized with COVID-19 reveal that the novel coronavirus is disproportionately affecting people with obesity, who are far more likely to experience severe complications compared with people without excess weight. Some of the most severe complications of COVID-19 — namely, acute respiratory failure or acute respiratory distress syndrome — can be driven by conditions already present in a person with obesity, such as chronic, low-grade inflammation and hypoventilation.

As health care providers across the United States grapple with the unknowns of treating a novel disease, management of patients with COVID-19, especially those who are critically ill, has varied widely. Therefore, on April 6, the American Thoracic Society released interim guidance to help clinicians standardize care.

A cohort of Chinese adults with diabetes but without other comorbidities were more likely to develop inflammatory storm leading to rapid deterioration in COVID-19 compared with adults without diabetes who contracted the novel coronavirus, study data from Wuhan show.